FDMT 4D Molecular Therapeutics, Inc.
4D Molecular Therapeutics, Inc. (FDMT) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
How much of that selling was preplanned? 97% planned / 3% discretionary
Largest single sale: $1.2M.
Where they traded
No open-market insider purchase on record.
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| Kirn David | See Remarks | Sell 10b5-1 | 58,333 | $13.90 | $811.0K | 767,486 −7.1% of holding | |
| Bizily Scott | Chief Legal Officer | Sell 10b5-1 | 584 | $14.00 | $8.2K | 8,617 −6.3% of holding | |
| Kirn David 2 fills | See Remarks | Sell 10b5-1 | 69,076 | $15.75 | $1.1M | 851,746 −7.5% of holding | |
| Bizily Scott | Chief Legal Officer | Sell 10b5-1 | 1,635 | $12.20 | $19.9K | 8,617 −15.9% of holding | |
| Bizily Scott | Chief Legal Officer | Sell 10b5-1 | 1,635 | $12.00 | $19.6K | 8,617 −15.9% of holding | |
| Kirn David | See Remarks | Sell 10b5-1 | 26,842 | $10.23 | $274.6K | 844,895 −3.1% of holding | |
| Kirn David | See Remarks | Sell 10b5-1 | 12,415 | $10.05 | $124.7K | 871,737 −1.4% of holding | |
| Kirn David 2 fills | See Remarks | Sell 10b5-1 | 15,725 | $12.03 | $189.2K | 884,594 −1.7% of holding | |
| Kirn David | See Remarks | Sell 10b5-1 | 42,608 | $12.87 | $548.2K | 899,877 −4.5% of holding | |
| Bizily Scott | Chief Legal Officer | Sell 10b5-1 | 6,566 | $14.00 | $91.9K | 8,617 −43.2% of holding |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.